This detailed analysis examines the AC-262 SARM formulation to assess its chemical purity, active compound concentration, and overall quality parameters. The assessment employs advanced analytical techniques to validate product quality and ensure compliance with standards for selective androgen receptor modulators.
HPLC and General Dissolution Assay: High Performance Liquid Chromatography provides precise separation and quantification of the SARM compound, while General Dissolution Assay evaluates the release characteristics through controlled dissolution testing.
| Parameter | Value |
|---|---|
| Sample Identification | AC 262 (Lot# 518392746-BCD-2024) |
| Dosagen | 10mg/tab |
| Manufacturer: | Vitasarm |
| Concentration | 8.37 mg/tab |
| Purity | 83.7 |
| Impurities | < 16.3% |
The analytical assessment reveals that the AC-262 SARM formulation exhibits good purity levels at 83.7%, within acceptable ranges for research compound preparations. Chromatographic analysis showed well-defined peaks corresponding to the active compound with minimal interference from excipients. Dissolution testing demonstrated appropriate release profiles, and concentration determination confirmed consistent values across multiple samples, indicating proper manufacturing control.
The AC-262 SARM formulation meets established quality specifications with satisfactory purity levels and accurate concentration values. The product demonstrates appropriate manufacturing consistency, confirming its suitability for research applications requiring reliable selective androgen receptor modulators with consistent quality characteristics.
